1. Salmonella infections in a cancer center.
- Author
-
Noriega LM, Van der Auwera P, Daneau D, Meunier F, and Aoun M
- Subjects
- Adolescent, Adult, Aged, Bacteremia epidemiology, Belgium epidemiology, Cancer Care Facilities, Community-Acquired Infections epidemiology, Female, Focal Infection epidemiology, Humans, Male, Middle Aged, Neoplasms drug therapy, Neoplasms surgery, Recurrence, Salmonella isolation & purification, Salmonella Infections microbiology, Salmonella enteritidis isolation & purification, Salmonella typhimurium isolation & purification, Survival Rate, Neoplasms therapy, Salmonella Infections epidemiology
- Abstract
Data concerning 40 patients hospitalized in a cancer center and Salmonella infection were analyzed. Hematological malignancy was present in 24 patients (60%) and solid tumor in 14 patients (35%). Among the predisposing factors, antineoplastic chemotherapy was the most frequent (60%) followed by antacid use (47.5%), corticosteroids (37.5%), granulocytopenia below 500 neutrophils/microliters (15%), surgery (10%) and splenectomy (2.5%). Bacteremia was the most frequent clinical syndrome accounting for 42.5% of the patients. Focal infection, enteritis and carrier state accounted for the remaining 30%, 20% and 7.5% respectively. Salmonella typhimurium and S. dublin represented 65% of the isolates, with clear association between serotype dublin and bacteremia. All S. dublin isolates were resistant to chloramphenicol. Among dublin and typhimurium serotypes, 20% the isolates were resistant to the traditional antibiotics used in salmonellosis (ampicillin, chloramphenicol, cotrimoxazole). All strains were susceptible in vitro to cephalosporins. The frequency of relapse was 15% and the overall mortality (within 30 days) attributed to Salmonella infection was 15%.
- Published
- 1994
- Full Text
- View/download PDF